These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 2951501

  • 1. A pilot clinical trial of the toxicity and immunorestorative effects of T cell reconstituting factor (SR 270258) in immunosuppressed cancer patients.
    Murray JL, Reuben JM, Smith TL, Gehan EA, Koretz SM, Hersh EM.
    J Biol Response Mod; 1987 Feb; 6(1):56-68. PubMed ID: 2951501
    [Abstract] [Full Text] [Related]

  • 2. Effects of combined immunotherapy with levamisole and Bacillus Calmette-Guérin on immunocompetence of patients with squamous cell carcinoma of the cervix, head and neck, and lung undergoing radiation therapy.
    Olkowski ZL, McLaren JR, Skeen MJ.
    Cancer Treat Rep; 1978 Nov; 62(11):1651-61. PubMed ID: 310339
    [Abstract] [Full Text] [Related]

  • 3. Effect of thymosin and irradiation on immune modulation in head and neck and esophageal cancer patients.
    Wara WM, Ammann AJ, Wara DW.
    Cancer Treat Rep; 1978 Nov; 62(11):1775-8. PubMed ID: 728896
    [Abstract] [Full Text] [Related]

  • 4. Clinical studies of methanol extraction residue fraction of Bacillus Calmette-Guérin as an immunostimulant in patients with advanced cancer.
    Moertel CG, Ritts RE, Schutt AJ, Hahn RG.
    Cancer Res; 1975 Nov; 35(11 Pt 1):3075-83. PubMed ID: 1102082
    [Abstract] [Full Text] [Related]

  • 5. Cellular immunity in patients with epidermoid cancer of the head and neck.
    Papenhausen PR, Kukwa A, Croft CB, Borowiecki B, Silver C, Emeson EE.
    Laryngoscope; 1979 Apr; 89(4):538-49. PubMed ID: 311881
    [Abstract] [Full Text] [Related]

  • 6. Lymphocyte profiles in patients with chronic low back pain enrolled in a clinical trial.
    Brennan PC, Graham MA, Triano JJ, Hondras MA, Anderson RJ.
    J Manipulative Physiol Ther; 1994 May; 17(4):219-27. PubMed ID: 8046277
    [Abstract] [Full Text] [Related]

  • 7. Immune status in Crohn's disease. VI. Immunoregulation evaluated by multiple, distinct T-suppressor cell assays of lymphocyte proliferation, and by enumeration of immunoregulatory T-lymphocyte subsets.
    Auer IO, Röder A, Fröhlich J.
    Gastroenterology; 1984 Jun; 86(6):1531-43. PubMed ID: 6232166
    [Abstract] [Full Text] [Related]

  • 8. Assessment of phenotype of blood lymphocyte subsets prior and after PWM stimulation in patients with lung carcinoma.
    Jezewska E, Górny MK, Skrzypczak A, Słowik-Gabryelska A, Zeromski J.
    Arch Geschwulstforsch; 1989 Jun; 59(1):31-6. PubMed ID: 2923522
    [Abstract] [Full Text] [Related]

  • 9. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
    [Abstract] [Full Text] [Related]

  • 10. Functional analysis of human T cell subsets defined by monoclonal antibodies. VI. Distinct and opposing immunoregulatory functions within the OKT8+ population.
    Thomas Y, Rogozinski L, Rabbani L, Chess A, Goldstein G, Chess L.
    J Mol Cell Immunol; 1984 Dec; 1(2):103-13. PubMed ID: 6152892
    [Abstract] [Full Text] [Related]

  • 11. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287
    [Abstract] [Full Text] [Related]

  • 12. T-lymphocyte subsets in primary lung cancer.
    Tsuyuguchi I, Shiratsuchi H, Fukuoka M.
    Jpn J Clin Oncol; 1987 Mar; 17(1):13-7. PubMed ID: 3494139
    [Abstract] [Full Text] [Related]

  • 13. Active T-rosette-forming cells in the peripheral blood of cancer patients.
    Kerman RH, Smith R, Stefani SS, Ezdinili EZ.
    Cancer Res; 1976 Sep; 36(9 pt.1):3274-8. PubMed ID: 1086131
    [Abstract] [Full Text] [Related]

  • 14. A pilot clinical trial of vaccination with dendritic cells pulsed with autologous tumor cells derived from malignant pleural effusion in patients with late-stage lung carcinoma.
    Chang GC, Lan HC, Juang SH, Wu YC, Lee HC, Hung YM, Yang HY, Whang-Peng J, Liu KJ.
    Cancer; 2005 Feb 15; 103(4):763-71. PubMed ID: 15637694
    [Abstract] [Full Text] [Related]

  • 15. Critical evaluation of lymphocyte functions in urological cancer patients.
    Elhilali MM, Paika KD, Brosman S, Fahey JL.
    Cancer Res; 1976 Jan 15; 36(1):132-7. PubMed ID: 1082369
    [Abstract] [Full Text] [Related]

  • 16. Combined-modality treatment of inoperable lung cancer (i.v. immunotherapy, chemotherapy, and radiotherapy).
    Robinson E, Haim N, Segal R, Veseley Z, Mekori T.
    Cancer Treat Rep; 1985 Mar 15; 69(3):251-8. PubMed ID: 2983892
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.